Xenpozyme is a treatment for ASMD and the condition’s only current enzyme replacement therapy
from PharmaTimes: News RSS https://ift.tt/Ya7Ukyd
Post Top Ad
Friday, 1 July 2022
Sanofi’s Xenpozyme approved by European Commission
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment